<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />



<meta name="date" content="2026-02-13" />

<title>ALKYLAMINE</title>

<script src="rmdlib/header-attrs-2.30/header-attrs.js"></script>
<script src="rmdlib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="rmdlib/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="rmdlib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="rmdlib/navigation-1.1/tabsets.js"></script>
<script src="rmdlib/accessible-code-block-0.0.1/empty-anchor.js"></script>
<link href="rmdlib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="rmdlib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<meta name="description" content="Indian equities analysis, margin reports, risk, etc..." />
<meta property="og:image" content="https://avatars3.githubusercontent.com/u/21966469?s=400&v=4" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>










<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">StockViz</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-globe"></span>
     
    Macro
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-bnd.html">Fixed Income</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cur.html">Currencies</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cmdy.html">Commodities</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-arrows-v"></span>
     
    52w H&amp;L
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-rocket"></span>
     
    ATH
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-magnet"></span>
     
    Drawdowns
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-train"></span>
     
    Streaks
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-hand-pointer-o"></span>
     
    Indian Indices
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-risk.html">Performance Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-IN.html">Index Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-MKT-CAP.html">Classification Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-industry.html">Industry Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-syn.html">Synthetic Indices</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-vol-NIFTY.html">NIFTY Volatility</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-valuations.html">Valuations</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/results-IN.html">Result Dates</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/eq-in/rp-margin.html">Margin Report</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-shopping-bag"></span>
     
    Funds
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports03/mf/rp-IN.html">Indian Mutual Funds</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports03/pms/rp-IN.html">Indian PMS</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-risk.html">US ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-sector.html">US Sector ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-country.html">Country $ ETFs</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-percent"></span>
     
    Fama-French
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-industry.html">Industry</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-factors.html">Factors</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-regression.html">Regressions</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://stockviz.biz">
    <span class="fa fa-home"></span>
     
  </a>
</li>
<li>
  <a href="https://stockviz.substack.com">
    <span class="fa fa-envelope-o"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">ALKYLAMINE</h1>
<h3 class="subtitle">Equity Metrics</h3>
<h4 class="date">February 13, 2026</h4>

</div>


<div id="alkyl-amines-chemicals-limited" class="section level1">
<h1>Alkyl Amines Chemicals Limited</h1>
<p><a href="/reports01/index/industry/rp-SpecialtyChemicals.html">Specialty Chemicals</a></p>
<div id="annual-returns" class="section level2">
<h2>Annual Returns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.fan.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.annret.png" /></p>
</div>
<div id="cumulative-returns-and-drawdowns" class="section level2">
<h2>Cumulative Returns and Drawdowns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.cumret.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.sma.cumret.png" /></p>
<p><br><br></p>
</div>
<div id="fundamentals" class="section level2">
<h2>Fundamentals</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.eps.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.RevenueFromOperations.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.ebit.png" /></p>
<p><br><br></p>
</div>
<div id="ownership" class="section level2">
<h2>Ownership</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.ownership.png" /></p>
<p><br><br></p>
</div>
<div id="margined" class="section level2">
<h2>Margined</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.ALKYLAMINE.mtf.png" /></p>
<p><br><br></p>
<p><br />
</p>
</div>
<div id="ai-summary" class="section level2">
<h2>AI Summary</h2>
<p><em>asof: 2025-12-03 </em></p>
<div id="analysis-of-alkyl-amines-chemicals-limited-alkylamine" class="section level3">
<h3>Analysis of Alkyl Amines Chemicals Limited (ALKYLAMINE)</h3>
<p>Alkyl Amines Chemicals Limited (ALKYLAMINE), a specialty chemicals manufacturer focused on amines (methylamines, ethylamines), derivatives, and niche products like acetonitrile, reported subdued H1 FY26 results amid demand and pricing pressures. Revenue declined ~2% YoY to ₹795 Cr, with PAT down ~4% to ₹92 Cr, but margins remained resilient (PBT margins ~16%). Volumes grew marginally, crossing 100k tons run-rate (total saleable capacity ~1.5 lakh tons). Balance sheet remains robust (net cash positive, low debt). Below is a structured analysis based on the earnings transcript, financial results, and disclosures.</p>
<div id="headwinds-current-challenges" class="section level6">
<h6>Headwinds (Current Challenges)</h6>
<ul>
<li><strong>Geopolitical and Trade Pressures</strong>: US sanctions/tariffs impacted ~1% direct exports and ~5-6% indirect via pharma/customers. Chinese aggression (dumping in ex-US markets) eroded domestic pricing and market share, particularly in methylamines.</li>
<li><strong>Demand Slackness</strong>: Subdued volumes/prices across segments; FY26 growth expected below historical 10-15%. Ethylamines saw price erosion (contribution margin hit harder YoY), methylamines lost volumes due to capacity overhang.</li>
<li><strong>Capacity Overhang in Methylamines</strong>: Market ~80-90k tons vs. &gt;150k tons capacity (Balaji, RCF, Alkyl, new entrant Aarti Drugs at 50-60k tons). Self-consumption (20-40%) limits merchant sales.</li>
<li><strong>Raw Material Volatility</strong>: Ammonia prices spiked due to Middle East disruptions/Iran sanctions; short-term supply chain adjustments expected, with temporary cost blips.</li>
<li><strong>Working Capital Drag</strong>: Sharp drop in trade payables led to lower operating cash flow (₹75 Cr vs. ₹164 Cr YoY).</li>
</ul>
</div>
<div id="tailwinds-supportive-factors" class="section level6">
<h6>Tailwinds (Supportive Factors)</h6>
<ul>
<li><strong>Margin Resilience</strong>: Gross margins stable despite flat topline; cost controls protected EBITDA/PAT.</li>
<li><strong>Strong Balance Sheet</strong>: Zero short-term borrowings (repaid ₹3.6 Cr), ₹165 Cr cash/bank balances, ROCE intact. Asset turnover targeted at 1.5x for new projects.</li>
<li><strong>Product Diversification</strong>: No single product &gt;20% of revenue; derivatives ~30% of amine output provide buffer.</li>
<li><strong>Anti-Dumping Protection</strong>: Duties on acetonitrile (Indian market 30-35k tons, prior imports ~40%) effective June 2025; muted Q2 impact due to pre-duty stockpiling, but volumes/prices expected to improve from Q4 FY26.</li>
<li><strong>Domestic Focus</strong>: Ethylamines largely insulated (domestic competition, 60-70% utilization in new 30k ton plant).</li>
</ul>
</div>
<div id="growth-prospects" class="section level6">
<h6>Growth Prospects</h6>
<ul>
<li><strong>New Product Launch</strong>: Rs120 Cr CAPEX at Kurkumbh (mechanical completion Feb-Mar 2026, commercialization Q1 FY27). Import-substitute for dyes/pigments/electronics; superior tech vs. China, expected profitable with 1.5x asset turnover.</li>
<li><strong>Acetonitrile Upside</strong>: Pharma-grade monopoly in India; growth from GLP-1 drugs (e.g., semaglutide peptides). Capacity utilization to rise (current ~15-16k tons sales); potential expansion (Rs150-160 Cr for 10k tons, 2-year timeline) if market grows to 20k tons in 2 years. Exports ongoing.</li>
<li><strong>Volume Expansion</strong>: Run-rate &gt;100k tons (vs. FY25 crossed); total capacity up to 2 lakh tons production (1.5 lakh saleable). DEK (agrochemical derivative) stabilizing post-initial hiccups.</li>
<li><strong>R&amp;D Pipeline</strong>: 2-3 products in evaluation (3-6 months decisions); aligned with core tech (specialties beyond amines).</li>
<li><strong>Other Catalysts</strong>: Isopropylamine anti-dumping decision by Mar 2026; agrochem/pharma recovery post-subdued H1.</li>
</ul>
<table>
<thead>
<tr class="header">
<th>Key Metric</th>
<th>H1 FY26</th>
<th>H1 FY25</th>
<th>FY25</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Volumes</strong></td>
<td>Marginally up (~100k+ run-rate)</td>
<td>-</td>
<td>13% growth</td>
</tr>
<tr class="even">
<td><strong>Revenue</strong></td>
<td>₹795 Cr (-2%)</td>
<td>₹815 Cr</td>
<td>₹1,572 Cr</td>
</tr>
<tr class="odd">
<td><strong>PAT</strong></td>
<td>₹92 Cr (-4%)</td>
<td>₹96 Cr</td>
<td>₹186 Cr</td>
</tr>
<tr class="even">
<td><strong>EPS (Basic)</strong></td>
<td>₹18.06</td>
<td>₹18.84</td>
<td>₹36.40</td>
</tr>
</tbody>
</table>
</div>
<div id="key-risks" class="section level6">
<h6>Key Risks</h6>
<table>
<colgroup>
<col width="37%" />
<col width="32%" />
<col width="30%" />
</colgroup>
<thead>
<tr class="header">
<th>Risk Category</th>
<th>Description</th>
<th>Mitigation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Competition</strong></td>
<td>Chinese dumping; Aarti’s methylamine ramp-up eroding pricing/volumes.</td>
<td>Tech edge, anti-dumping duties, import-substitutes.</td>
</tr>
<tr class="even">
<td><strong>Geopolitical/Trade</strong></td>
<td>Prolonged US/China tensions, Iran sanctions disrupting RM supply/pricing.</td>
<td>Diversified exports (US &lt;1%), domestic focus, flexible supply chains.</td>
</tr>
<tr class="odd">
<td><strong>Execution</strong></td>
<td>New product delays (e.g., env. clearances, ramp-up); ACN competitor expansions (e.g., 60k ton plant).</td>
<td>Proven track record; Q1 FY27 commercialization targeted.</td>
</tr>
<tr class="even">
<td><strong>Macro/Demand</strong></td>
<td>Subdued pharma/agrochem (e.g., GLP drugs unproven scale); inventory overhang.</td>
<td>Multi-segment exposure; historical 10-15% CAGR resilience.</td>
</tr>
<tr class="odd">
<td><strong>RM/Cost</strong></td>
<td>Ammonia/methanol spikes (5-10% cost base).</td>
<td>Pass-through pricing; global overhang limits sustained rises.</td>
</tr>
<tr class="even">
<td><strong>Regulatory</strong></td>
<td>Anti-dumping delays (e.g., isopropylamine); remuneration approvals (postal ballot).</td>
<td>Strong governance; no material impact.</td>
</tr>
</tbody>
</table>
</div>
<div id="summary" class="section level6">
<h6>Summary</h6>
<p>ALKYLAMINE faces near-term headwinds from geopolitics, Chinese competition, and methylamine oversupply, capping FY26 growth at low-single digits (vs. 10-15% norm) and pressuring prices/volumes. However, tailwinds like stable margins, debt-free status, and acetonitrile protection provide downside buffers. Growth prospects shine in H2 FY26/FY27 via new product (high-margin import sub), ACN pharma tailwinds, and R&amp;D pipeline, targeting steady 10%+ CAGR long-term. <strong>Investment Thesis</strong>: Hold/Buy on dips for 25-30x FY27E PE; risks skewed to trade wars but balanced by execution strength. Monitor Q3 results for volume inflection and RM stability.</p>
</div>
</div>
</div>
</div>

&nbsp;
&nbsp;
<hr />
<p style="text-align: center;">Copyright &copy; 2023 SAS Data Analytics Pvt. Ltd. All rights reserved.</p>
<p style="text-align: center;"><a href="https://github.com/stockviz/reports/issues">&#x1F41E;</a></p>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
